Environmental and occupational bronchiolitis obliterans: new reality

Gutor, Sergey S.; Miller, Robert F.; Blackwell, Timothy S.; Polosukhin, Vasiliy V.

doi:10.1016/j.ebiom.2023.104760

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Book1

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 71 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Occupational Immunotoxicology

Anderson,

Weatherly,

Meade

2024

Reference Module in Biomedical Sciences

View full text Add to dashboard Cite

Occupational Immunotoxicology

Anderson,

Weatherly,

Meade

2024

Reference Module in Biomedical Sciences

View full text Add to dashboard Cite

Pulmonary vascular disease in Veterans with post-deployment respiratory syndrome

Gutor,

Richmond,

Agrawal

et al. 2024

Cardiovascular Pathology

View full text Add to dashboard Cite

Traditional Chinese Herbal Medicine: Therapeutic Potential in Chronic Obstructive Pulmonary Disease

Shi,

Liu,

Shengbu

et al. 2024

Natural Product Communications

View full text Add to dashboard Cite

Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow obstruction and manifested by symptoms such as chronic cough, sputum, and dyspnea. Traditional Chinese medicine (TCM) has long been used to treat COPD. This article summarizes potential Chinese herbal medicines (CHM) for COPD treatment through a literature review and collation. The findings highlight 14 kinds of effective CHM for COPD, including Scutellaria radix, Salvia miltiorrhiza radix et rhizoma, Hippophae fructus, Ginseng radix et rhizoma, and Astragali radix. Flavonoids, terpenoids, alkaloids, and volatile oil constituents are the main bioactive components for the treatment of COPD. They mainly inhibit the tumor necrosis factor alpha/nuclear factor kappa B (TNF-α/NF-κB) signaling pathway by reducing the production and release of inflammatory factors such as interleukin 1 beta (IL-1β), interleukin 6 (IL-6), interleukin 8 (IL-8), TNF-α, and NF-κB, thereby reducing inflammation in lungs of rats with COPD and protect the lung tissues. Some active ingredients can inhibit toll-like receptor 4 (TLR4), mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase-protein kinase B (PI3K-Akt), Janus kinase-signal transducer and activator of transcription (JAK-STAT), and transforming growth factor beta (TGF-β) signaling pathways to express anti-inflammatory activity. This work establishes a foundation for using CHM in COPD treatment and offers new insights and approaches for developing novel anti-COPD drugs.

show abstract

Environmental and occupational bronchiolitis obliterans: new reality

Cited by 3 publications

References 71 publications

Occupational Immunotoxicology

Occupational Immunotoxicology

Pulmonary vascular disease in Veterans with post-deployment respiratory syndrome

Traditional Chinese Herbal Medicine: Therapeutic Potential in Chronic Obstructive Pulmonary Disease

Contact Info

Product

Resources

About